Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy (Q46705414)

24 December 2017

title

Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy (English)

1 reference

24 December 2017

author name string

Rania A Elrashidy

series ordinal

1

1 reference

24 December 2017

Mervat E Asker

series ordinal

2

1 reference

24 December 2017

Hoda E Mohamed

series ordinal

3

1 reference

24 December 2017

publication date

18 January 2012

1 reference

24 December 2017

Journal of Cardiovascular Pharmacology and Therapeutics

published in

1 reference

24 December 2017

volume

17

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

324-333

1 reference

24 December 2017

Cardiovascular disease in diabetic nephropathy patients: cell adhesion molecules as potential markers?

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Effects of diabetes mellitus, pressure-overload and their association on myocardial structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

The relationship between myocardial extracellular matrix remodeling and ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Redefining the role of thiazolidinediones in the management of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Animal model of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Angiotensin II regulates cardiac hypertrophy via oxidative stress but not antioxidant enzyme activities in experimental renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Pioglitazone, a thiazolidinedione derivative, attenuates left ventricular hypertrophy and fibrosis in salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Cardiovascular disease in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Cardioprotective effect of vitamin E: rescues of diabetes-induced cardiac malfunction, oxidative stress, and apoptosis in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Oxidative stress, diabetes, and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Cardiac fibroblasts: at the heart of myocardial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

The roles of MMP-2/TIMP-2 in extracellular matrix remodelling in the hearts of STZ-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Effects of pioglitazone on hyperglycemia-induced alterations in antioxidative system in tissues of alloxan-treated diabetic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Diabetic cardiomyopathy: the search for a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Effects of metformin on rosiglitazone-induced cardiac hypertrophy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1074248411431581

21 January 2018

Identifiers

DOI

10.1177/1074248411431581

1 reference

24 December 2017

PubMed ID

22261714

1 reference

24 December 2017